Capital Flow Monitor · Sponsors · CIK 2145246
Baylor Genetics Holdings, Inc.
2450 HOLCOMBE BLVD., SUITE 2210, HOUSTON, TX, 77021 · 800-411-4363
Other Health Care · Corporation· inc. DELAWARE true 2025
Fit score
—
Offering
$100.0M
Sold
$50.0M
% sold
50.0%
Investors
13
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-16 | D ·current | 506(b) | $100.0M | $50.0M | 50.0% | 13 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Kengo Takishima — Executive Officer / Director, Houston, TX
- Brendan Lee — Director, Houston, TX
-
Victor Tong — Director, Houston, TX
1 other raise
- Harton, Inc. $15.1M of $18.1M · 83.4%
-
Xiangmin Cui — Director, Houston, TX
3 other raises
- Decheng Capital Global Healthcare Fund, LP $139.0M of —
- Decheng Capital Global Healthcare Fund (Offshore), LP $33.1M of —
- Decheng Capital Global Life Sciences Fund V, L.P. $452.0M of $700.0M · 64.6%
- Goki Ishikawa — Director, Houston, TX
-
Joel Kaufman — Executive Officer, Houston, TX
1 other raise
- PrognomIQ, Inc. $11.9M of $11.9M · 100.0%
- David Berger — Executive Officer, Houston, TX
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.